In east China-located Huai'an, a premier food expo in northern Yangtze River Delta kicked off on Thursday, gathering experts from home and abroad to share wisdom on vitalizing food industry and...

On the 2nd day of Phase 1 of the 134th Canton Fair, the atmosphere remained vibrant. The "Hardware Tools" section attracted a total of 2,780 top-tier companies from the industry in the onsite...

SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active Crohn's disease who have failed one or more...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today...

PT-112's mechanism of action promotes immunogenic cancer cell death through ribosomal biogenesis inhibition and organelle stress NEW YORK, Oct. 14, 2023 /PRNewswire/ -- Promontory Therapeutics...